Skip to main content
logo
Advagene Biopharma Co., Ltd. (TPEX:6709)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.45
+0.65 (2.73%)
Sep 15, 2026, 1:29 PM CST

Advagene Biopharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,0771,6661,2201,3551,4792,396
Market Cap Growth
-39.73%36.50%-9.95%-8.37%-38.27%63.30%
Enterprise Value
9171,5021,1301,2941,3222,125
Last Close Price
24.4527.9120.4525.2829.5948.08

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.0210.945.539.6811.229.60
P/TBV Ratio
3.0910.945.539.6812.139.96

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.030.03-0.020.02
Net Debt / Equity Ratio
-0.91-0.86-0.89-0.89-0.77-0.88
Net Debt / EBITDA Ratio
3.581.852.791.400.882.47
Net Debt / FCF Ratio
3.571.992.761.610.923.25
Quick Ratio
44.1913.6331.5618.2514.5129.07
Current Ratio
44.3213.6931.6318.3714.9429.50
Return on Equity (ROE)
-33.48%-36.64%-38.51%-67.80%-62.09%-33.77%
Return on Assets (ROA)
-20.63%-22.23%-23.29%-40.40%-37.32%-20.47%
Return on Capital Employed (ROCE)
-26.00%-45.80%-31.50%-66.70%-90.50%-37.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.45%-4.10%-5.69%-6.80%-8.00%-3.87%
FCF Yield
-8.41%-3.94%-5.83%-5.73%-7.41%-2.83%
Buyback Yield / Dilution
-4.15%-8.64%-8.47%-2.14%-1.23%-9.95%